Changes in plasma hydrogen sulfide and nitric oxide levels and their clinical significance in children with Kawasaki disease

Chinese Medical Journal

Volumn 124, Issue 21, 2011, Pages 3445-3449

  Li, Xiao Hui ^a   Zhang, Chao Ying ^a   Wu, Jian Xin ^a   Zhang, Ting ^a  

^a CAPITAL INSTITUTE OF PEDIATRICS   (China)

Author keywords

Hydrogen sulfide; Kawasaki disease; Nitric oxide

Indexed keywords

CREATINE KINASE MB; HYDROGEN SULFIDE; IMMUNOGLOBULIN; NITRATE REDUCTASE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; SULFUR; TROPONIN I;

ARTICLE; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; CORONARY ARTERY DISEASE; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAPHY; ENZYME ACTIVITY; FEMALE; HUMAN; INFLAMMATION; MALE; MUCOCUTANEOUS LYMPH NODE SYNDROME; PATHOPHYSIOLOGY; PRESCHOOL CHILD; SINUS TACHYCARDIA;

CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; HYDROGEN SULFIDE; INFANT; MALE; MUCOCUTANEOUS LYMPH NODE SYNDROME; NITRIC OXIDE;

EID: 82255195589     PISSN: 03666999     EISSN: None     Source Type: Journal    
DOI: 10.3760/cma.j.issn.0366-6999.2011.21.002     Document Type: Article

References (17)

1. Mitchell JA, Ali F, Bailey L, Moreno L, Harrington LS. Role of nitric oxide and prostacyclin as vasoactive hormones released by the endothelium. Exp Physiol 2008; 93: 141-147.
2. Du J, Hui Y, Cheung Y, Bin G, Jiang H, Chen X, et al. The possible role of hydrogen sulfide as a smooth muscle cell proliferation inhibitor in rat cultured cells. Heart Vessels 2004; 19: 75-80.
3. Bełtowski J, Jamroz-Wiśniewska A, Tokarzewska D. Hydrogen sulfide and its modulation in arterial hypertension and atherosclerosis. Cardiovasc Hematol Agents Med Chem 2010; 8: 173-186.
4. Qiao W, Chaoshu T, Hongfang J, Junbao D. Endogenous hydrogen sulfide is involved in the pathogenesis of atherosclerosis. Biochem Biophys Res Commun 2010; 396: 182-186.
5. Wang XB, Jin HF, Tang CS, Du JB. Significance of endogenous sulphur-containing gases in the cardiovascular system. Clin Exp Pharmacol Physiol 2010; 37: 745-752.
6. Newburger JW, Takahashi M, Gerber MA, Gewitz MH, Tani LY, Burns JC, et al. Diagnosis, treatment, and long-term management of Kawasaki disease: a statement for health professionals from the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease in the Young, American Heart Association. Pediatrics 2004; 115: 1708-1733.
7. Adewuya O, Irie Y, Bian K, Onigu-Otite E, Murad F. Mechanism of vasculitis and aneurysms in Kawasaki disease: role of nitric oxide. Nitric Oxide 2003; 8: 15-25.
8. Li X, Jin H, Bin G, Wang L, Tang C, Du J. Endogenous hydrogen sulfide regulates pulmonary artery collagen remodeling in rats with high pulmonary blood flow. Exp Biol Med (Maywood) 2009; 234: 504-512.
9. Fiorucci S. Hydrogen sulfide: from physiology to pharmacology. Inflamm Allergy Drug Targets 2011; 10: 77-84.
10. Zanardo RC, Brancaleone V, Distrutti E, Fiorucci S, Cirino G, Wallace JL. Hydrogen sulfide is an endogenous modulator of leukocyte-mediated inflammation. FASEB J 2006; 20: 2118-2120.
11. Zagli G, Patacchini R, Trevisani M, Abbate R, Cinotti S, Gensini GF, et al. Hydrogen sulfide inhibits human platelet aggregation. Eur J Pharmacol 2007; 559: 65-68.
12. Ikemoto Y, Ogino H, Teraguchi M, Kobayashi Y. Evaluation of preclinical atherosclerosis by flow-mediated dilatation of the brachial artery and carotid artery analysis in patients with a history of Kawasaki disease. Pediatr Cardiol 2005; 26: 782-786.
13. Ikeda K, Yamaguchi K, Tanaka T, Mizuno Y, Hijikata A, Ohara O, et al. Unique activation status of peripheral blood mononuclear cells at acute phase of Kawasaki disease. Clin Exp Immunol 2010; 160: 246-255.
14. Hegde A, Bhatia M. Hydrogen sulfide in inflammation: friend or foe? Inflamm Allergy Drug Targets 2011; 10: 118-122.
15. Ikemoto Y, Teraguchi M, Ono A, Kino M, Yoshimura K, Kobayashi Y. Serial changes of plasma nitrate in the acute phase of Kawasaki disease. Pediatr Int 2003; 45: 421-425.
16. Li L, Bhatia M, Zhu YZ, Zhu YC, Ramnath RD, Wang ZJ, et al. Hydrogen sulfide is a novel mediator of lipopolysaccharide-induced inflammation in the mouse. FASEB J 2005; 19: 1196-1198.
17. Freeman AF, Crawford SE, Cornwall ML, Garcia FL, Shulman ST, Rowley AH. Angiogenesis in fatal acute Kawasaki disease coronary artery and myocardium. Pediatr Cardiol 2005; 26: 578-584.